CLINICAL_TRIALS
research
· 2019-02-20
Clinical Trial Update: Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome
Summary
An update on a clinical trial evaluating acetazolamide for the management of alkalosis in Bartter syndrome; current status of the trial is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tehran University of Medical Sciences | Conditions: Bartter Syndrome | Status: UNKNOWN